Mark Bertolini Sells 624,244 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CEO Mark Bertolini sold 624,244 shares of the firm’s stock in a transaction dated Tuesday, June 30th. The shares were sold at an average price of $28.48, for a total value of $17,778,469.12. Following the transaction, the chief executive officer directly owned 7,751,570 shares in the company, valued at approximately $220,764,713.60. This represents a 7.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Price Performance

OSCR stock opened at $32.09 on Friday. The firm has a market cap of $9.67 billion, a P/E ratio of -54.38, a P/E/G ratio of 2.23 and a beta of 2.34. The firm’s fifty day moving average is $24.18 and its 200 day moving average is $17.77. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.11 and a current ratio of 1.11. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $33.10.

Oscar Health (NYSE:OSCR) last issued its earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, topping the consensus estimate of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The company had revenue of $4.65 billion for the quarter, compared to the consensus estimate of $4.90 billion. During the same period in the previous year, the firm earned $0.92 earnings per share. The firm’s revenue for the quarter was up 52.6% on a year-over-year basis. Research analysts predict that Oscar Health, Inc. will post 0.47 earnings per share for the current year.

Institutional Trading of Oscar Health

Hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. boosted its stake in Oscar Health by 2.7% during the fourth quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock worth $297,477,000 after buying an additional 540,851 shares during the period. Geode Capital Management LLC grew its position in Oscar Health by 2.5% in the 4th quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company’s stock valued at $68,964,000 after acquiring an additional 116,430 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH grew its position in Oscar Health by 1,097.8% in the 4th quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 237,882 shares of the company’s stock valued at $3,418,000 after acquiring an additional 218,022 shares during the last quarter. BIT Capital GmbH increased its stake in Oscar Health by 545.0% in the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock worth $88,897,000 after purchasing an additional 5,227,152 shares during the period. Finally, Farallon Capital Management LLC increased its stake in Oscar Health by 146.5% in the 3rd quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company’s stock worth $68,886,000 after buying an additional 2,163,000 shares during the period. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on OSCR shares. UBS Group lifted their price target on Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, June 14th. Zacks Research downgraded shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 5th. Wolfe Research started coverage on Oscar Health in a research report on Tuesday, May 5th. They set a “peer perform” rating for the company. Finally, Robert W. Baird upped their target price on shares of Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Three equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $20.78.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.